Vericel Corp. (VCEL)
34.27
-0.70
(-2.00%)
USD |
NASDAQ |
May 27, 16:00
34.27
0.00 (0.00%)
After-Hours: 20:00
Vericel Cash from Investing (Quarterly) : -4.201M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Arbutus Biopharma Corp. | 2.199M |
| Marker Therapeutics, Inc. | 0.00 |
| Tenaya Therapeutics, Inc. | -0.011M |
| Moderna, Inc. | -76.00M |
| Curis, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 16.38M |
| Cash from Financing (Quarterly) | -2.979M |
| Free Cash Flow | 47.49M |
| Free Cash Flow Per Share (Quarterly) | 0.2979 |
| Free Cash Flow to Equity (Quarterly) | 16.97M |
| Free Cash Flow to Firm (Quarterly) | 15.29M |
| Free Cash Flow Yield | 2.70% |